DE69329933D1 - 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel - Google Patents

17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel

Info

Publication number
DE69329933D1
DE69329933D1 DE69329933T DE69329933T DE69329933D1 DE 69329933 D1 DE69329933 D1 DE 69329933D1 DE 69329933 T DE69329933 T DE 69329933T DE 69329933 T DE69329933 T DE 69329933T DE 69329933 D1 DE69329933 D1 DE 69329933D1
Authority
DE
Germany
Prior art keywords
alpha
androstan
aza
reductase
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329933T
Other languages
English (en)
Other versions
DE69329933T2 (de
Inventor
H Rasmusson
K Bakshi
F Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69329933D1 publication Critical patent/DE69329933D1/de
Publication of DE69329933T2 publication Critical patent/DE69329933T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
DE69329933T 1992-10-06 1993-10-06 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel Expired - Fee Related DE69329933T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95723192A 1992-10-06 1992-10-06
PCT/US1993/009585 WO1994007861A1 (en) 1992-10-06 1993-10-06 17β-CARBOXANILIDES OF 4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS

Publications (2)

Publication Number Publication Date
DE69329933D1 true DE69329933D1 (de) 2001-03-22
DE69329933T2 DE69329933T2 (de) 2001-07-19

Family

ID=25499272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329933T Expired - Fee Related DE69329933T2 (de) 1992-10-06 1993-10-06 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel

Country Status (6)

Country Link
US (1) US5693810A (de)
EP (1) EP0663924B1 (de)
AU (1) AU5323694A (de)
DE (1) DE69329933T2 (de)
LV (1) LV12721B (de)
WO (1) WO1994007861A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220064B (hu) * 1992-12-18 2001-10-28 Merck And Co. Inc. Eljárás 17béta-(N-monoszubsztituált-karbamoil)-4-aza-5alfa-androszt-1-én-3-ont tartalmazó krónikus prosztatitisz kezelésére alkalmas gyógyászati készítmény előállítására
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5817818A (en) * 1994-09-16 1998-10-06 Glaxo Wellcome Inc. Androstenones
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
CA2231041A1 (en) * 1995-09-15 1997-03-20 Raman K. Bakshi 4-azasteroids for treatment of hyperandrogenic conditions
USRE39056E1 (en) 1995-09-15 2006-04-04 Merck & Co, Inc. 4-Azasteroids for treatment of hyperandrogenic conditions
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US5998427A (en) * 1998-05-14 1999-12-07 Glaxo Wellcome Inc. Androstenones
US6645974B2 (en) * 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
CN1784236A (zh) * 2003-05-07 2006-06-07 麦克公司 雄激素受体调节剂及其使用方法
CN103554213A (zh) * 2012-01-05 2014-02-05 中国药科大学 4-氧杂-雄甾-3-酮-17β-酰胺类衍生物、其制备方法及其医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US5116983A (en) * 1988-04-18 1992-05-26 Merck & Co., Inc. Dehydrogenation process intermediates
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
US5710275A (en) * 1992-05-20 1998-01-20 Merck & Co., Inc. 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
CA2174234A1 (en) * 1993-11-04 1995-05-11 Raman K. Bakshi 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors

Also Published As

Publication number Publication date
WO1994007861A1 (en) 1994-04-14
LV12721A (lv) 2001-09-20
AU5323694A (en) 1994-04-26
EP0663924A1 (de) 1995-07-26
LV12721B (en) 2001-12-20
EP0663924A4 (de) 1995-10-04
US5693810A (en) 1997-12-02
EP0663924B1 (de) 2001-02-14
DE69329933T2 (de) 2001-07-19

Similar Documents

Publication Publication Date Title
DE69621626D1 (de) Acylierte derivate von melatonin und dessen analoge als arzneimittel
DE3770085D1 (de) Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel.
ATE219089T1 (de) Triazol-derivate als arzneimittel
DE69231123D1 (de) Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
DE10199002I2 (de) Substituierte thiazolidindion derivate
ATA900296A (de) Verwendung von n-glyoxylprolylesterverbindungen in arzneimitteln
DE59308338D1 (de) Kosmetische oder pharmazeutische Zubereitungen
ITRM920237A1 (it) Perfezionato impiego di medicinali broncodilatatori b2.
DE69329933D1 (de) 17-beta-carboxanilid derivate von 4-aza-5-alpha-androstan-3-one als 5-alpha-reduktase-hemmende arzneimittel
DE69726007D1 (de) Prodrogs und analoga von camptothecin und deren verwendung als arzneimittel
FI951789A0 (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
ATE217867T1 (de) N-(pyrimidinyl)-benzolsulfonamide als arzneimittel
ATA901688A (de) Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
DK86492D0 (da) Laegemiddel
DE69517768T2 (de) IMIDAZOLYLALKYLDERIVATE VON IMIDAZO [5,1-c][1,4]BENZOXAZIN-1-ON UND IHRE VERWENDUNG ALS ARZNEIMITTEL
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
ATE289195T1 (de) Verwendung von substituierten 4-amino-1- phenylbutan-2-ol-verbindungen als arzneimittel
NO921907D0 (no) Anvendelse av pyridinylpyrimidinderivater for beskyttelseav tekniske materialer
DE3769332D1 (de) Derivate von pyrido-menadion-additionsprodukten und verwendungen davon.
DE69521347D1 (de) Ketonitrilderivate, antibaktrielle mittel und sie enthaltende arzneimittel
DE69300614D1 (de) Derivate von Dicyclopentadien und von Harzsäure.
NL191736C (nl) Onverzadigde kamferderivaten en farmaceutische en kosmetische preparaten ervan.
DE69505530D1 (de) Guanylsäure derivate und ihre verwendung als arzneimittel
FI932768A (fi) Farmaceutiska mjuka gelatinkapslar innehaollande lysinklonixinat och foerfarande foer framstaellning av dessa

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee